Celgene’s treatment of follicular lymphoma, or FL, was granted orphan designation from the FDA, according to a post to the agency’s website. Reference Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on BMY:
- Truist healthcare analysts to hold an analyst/industry conference call
- Amgen price target cut at Piper on lower Otezla estimates
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
- Bristol-Myers initiated with an Overweight at Cantor Fitzgerald
- Schrodinger, Bristol-Myers amend development pact to include neurology